Table 2.
Metabolite | Baseline completers | Week 12 completers | t-value | p-value |
---|---|---|---|---|
Glx/Cr | 0.705 ± 0.089 | 0.646 ± 0.045 | 2.743 | 0.023 |
CRLB ± SD | 7.1 ± 1.7% | 6.9 ± 1.5% | ||
(CRLB Range) | (5.8–11.6%) | (5.4–10.2%) |
Cr, creatine; CRLB, Cramer-Rao Lower Bounds; Glx, glutamate + glutamine.
There were no significant differences in the raw amplitude of Cr between baseline (pre-drug) and week 12 (post-drug) t(9) = −0.889, p = 0.397. There were no significant differences between baseline to week 12 in metabolite peak line width, CRLBs, gray matter voxel content, or white matter voxel content.